Improving clinical care of patients in Nipah outbreaks: moving beyond 'compassionate use'.
Hassan MZ. et al, (2025), The Lancet regional health. Southeast Asia, 33
Clinical characterisation and outcomes of human clade IIb mpox virus disease - a European multicentre observational cohort study (MOSAIC).
Pesonel E. et al, (2025), Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Ebola disease: bridging scientific discoveries and clinical application.
Rojek A. et al, (2024), The Lancet. Infectious diseases
Therapeutics for Nipah virus disease: a systematic review to support prioritisation of drug candidates for clinical trials
Chan XHS. et al, (2024), The Lancet Microbe, 101002 - 101002
Group sequential designs for clinical trials when the maximum sample size is uncertain.
Yarahmadi A. et al, (2024), Stat Med
Presentation and outcomes of Lassa fever in children in Nigeria: a prospective cohort study (LASCOPE).
Duvignaud A. et al, (2024), Journal of the Pediatric Infectious Diseases Society
An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus an aminoglycoside + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial-an update to the published protocol.
Randremanana RV. et al, (2024), Trials, 25
Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms
Citarella BW. et al, (2024), Heliyon, 10, e29591 - e29591
Interpretations of Studies on SARS-CoV-2 Vaccination and Post-acute COVID-19 Sequelae.
Gonçalves BP. et al, (2024), Epidemiology (Cambridge, Mass.), 35, 368 - 371
High-dose corticosteroid therapy in COVID-19: the RECOVERY trial - Authors' reply.
Peto L. et al, (2024), Lancet (London, England), 403, 1339 - 1340
Expanded Access Programme for the use of tecovirimat for the treatment of monkeypox infection: A study protocol for an Expanded Access Programme.
Bourner J. et al, (2024), PloS one, 19
Evaluation of pragmatic oxygenation measurement as a proxy for Covid-19 severity
Swets MC. et al, (2023), Nature Communications, 14
The burden and dynamics of hospital-acquired SARS-CoV-2 in England
Cooper BS. et al, (2023), Nature, 623, 132 - 138
A multi-country analysis of COVID-19 hospitalizations by vaccination status
Gonçalves BP. et al, (2023), Med, 4, 797 - 812.e2
Author Correction: GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19
Pairo-Castineira E. et al, (2023), Nature, 619, E61 - E61
GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19.
Pairo-Castineira E. et al, (2023), Nature, 617, 764 - 768
Seroepidemiology of Lassa virus in pregnant women in Southern Nigeria: A prospective hospital-based cohort study.
Kayem ND. et al, (2023), PLoS neglected tropical diseases, 17
Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19
Kartsonaki C. et al, (2023), International Journal of Epidemiology, 52, 355 - 376
Transplacental transfer of Lassa IgG antibodies in pregnant women in Southern Nigeria: A prospective hospital-based cohort study.
Kayem ND. et al, (2023), PLoS neglected tropical diseases, 17